Skip to main content
. 2022 Apr 20;89(6):761–772. doi: 10.1007/s00280-022-04428-0

Fig. 1.

Fig. 1

Progression-free survival in eGFR < 60 and ≥ 60 mL/min/1.73 m2 groups in the combined analysis population (N = 2430)